Charles River Laboratories International, Inc. (NYSE: CRL) has acquired Celsis International Ltd.

Target
Company Name
Target
Country
Description

Sale of Celsis International Ltd., a private equity portfolio company, to Charles River Laboratories International, Inc. (NYSE: CRL) for $212 million

Global M&A Offices
Brown Gibbons Lang & Company (Global M&A USA)
Global M&A Advisory Advisor to the seller